These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1699282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S.
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [Abstract] [Full Text] [Related]

  • 23. Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity.
    Leiby JM, Snider KM, Kraut EH, Metz EN, Malspeis L, Grever MR.
    Cancer Res; 1987 May 15; 47(10):2719-22. PubMed ID: 2436757
    [Abstract] [Full Text] [Related]

  • 24. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma.
    Roberts JD, Smith MR, Feldman EJ, Cragg L, Millenson MM, Roboz GJ, Honeycutt C, Thune R, Padavic-Shaller K, Carter WH, Ramakrishnan V, Murgo AJ, Grant S.
    Clin Cancer Res; 2006 Oct 01; 12(19):5809-16. PubMed ID: 17020988
    [Abstract] [Full Text] [Related]

  • 25. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J.
    Ann Hematol; 1991 Jul 01; 63(1):1-4. PubMed ID: 1715191
    [Abstract] [Full Text] [Related]

  • 26. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Yang LY, Gandhi V.
    Semin Oncol; 1993 Oct 01; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [Abstract] [Full Text] [Related]

  • 27. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ.
    J Clin Oncol; 2008 Jan 10; 26(2):196-203. PubMed ID: 18182662
    [Abstract] [Full Text] [Related]

  • 28. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
    Von Hoff DD, Green S, Alberts DS, Stock-Novack DL, Surwit EA, Miller TP, Stephens RL.
    Am J Clin Oncol; 1991 Jun 10; 14(3):193-4. PubMed ID: 1709556
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
    Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD.
    J Clin Oncol; 1997 Feb 10; 15(2):458-65. PubMed ID: 9053466
    [Abstract] [Full Text] [Related]

  • 31. Pulmonary toxicity associated with fludarabine monophosphate.
    Hurst PG, Habib MP, Garewal H, Bluestein M, Paquin M, Greenberg BR.
    Invest New Drugs; 1987 Feb 10; 5(2):207-10. PubMed ID: 2443463
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar 10; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 34. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA, Mittelman A, Lichtman SM, Silver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA.
    J Clin Oncol; 1991 Sep 10; 9(9):1562-9. PubMed ID: 1714949
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
    Hagenbeek A, Eghbali H, Monfardini S, Vitolo U, Hoskin PJ, de Wolf-Peeters C, MacLennan K, Staab-Renner E, Kalmus J, Schott A, Teodorovic I, Negrouk A, van Glabbeke M, Marcus R.
    J Clin Oncol; 2006 Apr 01; 24(10):1590-6. PubMed ID: 16575010
    [Abstract] [Full Text] [Related]

  • 37. A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
    Elias L, Stock-Novack D, Head DR, Grever MR, Weick JK, Chapman RA, Godwin JE, Metz EN, Appelbaum FR.
    Leukemia; 1993 Mar 01; 7(3):361-5. PubMed ID: 7680398
    [Abstract] [Full Text] [Related]

  • 38. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
    Keating MJ, Kantarjian H, Talpaz M, Redman J, McCredie KB.
    Nouv Rev Fr Hematol (1978); 1988 Mar 01; 30(5-6):461-6. PubMed ID: 2464794
    [Abstract] [Full Text] [Related]

  • 39. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
    McLaughlin P, Robertson LE, Keating MJ.
    Cancer Treat Res; 1996 Mar 01; 85():3-14. PubMed ID: 9043771
    [No Abstract] [Full Text] [Related]

  • 40. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy].
    Papajík T, Faber E, Hubácek J, Slezák P, Raida L, Heczko M, Sulovská I, Jarosová M, Pikalová Z, Indrák K.
    Vnitr Lek; 1997 Jan 01; 43(1):25-8. PubMed ID: 9221561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.